Pfizer said its candidate to vaccinate against a potentially fatal infection that harms patients' bowels has received fast-track designation from the U.S. Food and Drug Administration.
via WSJ.com: US Business http://ift.tt/1qEtXDA
via WSJ.com: US Business http://ift.tt/1qEtXDA
Nessun commento:
Posta un commento